Phase 1Completed
The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers
A Single Dose, Randomized, Open-label, Two-way Crossover Food-effect Bioavailbility Study of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg Sustained Release Tablets Under Fasting and Fed Conditions in Healthy Volunteers
- Sponsor
- LG Chem (Industry)
- Enrolment
- 28 enrolled
- Conditions
- Healthy; Fasting; Fed
- Interventions
- Fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg
- Ages
- adults
- Registry
- NCT07396844
Full record on ClinicalTrials.gov
From the registry
This is a single dose, randomized, open-label, two-way crossover study to investigate the food-effect bioavailability of the fixed-dose combination of Gemigliptin/Dapagliflozin/Metformin 50/10/1000 mg in healthy volunteers under fasting and fed conditions.
Primary outcomes
- The plasma concentration of Gemigliptin, Dapagliflozin and Metformin.
History
Last registry update
Primary completion
Started
Registered